WAKAMOTO PHARMACEUTICAL CO revenue for the last year amounted to 7.74 B JPY, the most of which — 3.39 B JPY — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 4.46 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought WAKAMOTO PHARMACEUTICAL CO 7.74 B JPY, and the year before that — 7.47 B JPY.